202 related articles for article (PubMed ID: 28716233)
1.
Huhn K; Mennecke A; Linz P; Tschunko F; Kästle N; Nagel AM; Uder M; Dörfler A; Linker RA; Engelhorn T
J Neurol Sci; 2017 Aug; 379():163-166. PubMed ID: 28716233
[TBL] [Abstract][Full Text] [Related]
2. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
3. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
4. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
[TBL] [Abstract][Full Text] [Related]
5. Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló's concentric sclerosis.
Hardy TA; Tobin WO; Lucchinetti CF
Mult Scler; 2016 Jul; 22(8):986-92. PubMed ID: 27037180
[TBL] [Abstract][Full Text] [Related]
6. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
[TBL] [Abstract][Full Text] [Related]
7. Contralateral recurrence of tumefactive demyelination.
Khan MN; Guranda M; Essig M
Neuroradiol J; 2015 Oct; 28(5):493-7. PubMed ID: 26427896
[TBL] [Abstract][Full Text] [Related]
8. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
Yiu EM; Laughlin S; Verhey LH; Banwell BL;
J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
[TBL] [Abstract][Full Text] [Related]
9. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
[TBL] [Abstract][Full Text] [Related]
10. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.
Barbosa BC; Marchiori E; Leal Leidersnaider C; Brandao L; Castillo M
Neuroradiol J; 2019 Apr; 32(2):103-107. PubMed ID: 30667319
[TBL] [Abstract][Full Text] [Related]
11. Tumefactive Multiple Sclerosis Variants: Report of Two Cases of Schilder and Balo Diseases.
Ashrafi MR; Tavasoli AR; Alizadeh H; Zare Noghabi J; Parvaneh N
Iran J Child Neurol; 2017; 11(2):69-77. PubMed ID: 28698732
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Totaro R; Di Carmine C; Splendiani A; Torlone S; Patriarca L; Carrocci C; Sciamanna S; Marini C; Carolei A
Neurol Sci; 2016 Jul; 37(7):1113-7. PubMed ID: 27083895
[TBL] [Abstract][Full Text] [Related]
13. Tumefactive Demyelinating Lesions in a Patient with Multiple Sclerosis Developed two Days after the Injection of Rituximab.
Moghadasi AN
Acta Neurol Taiwan; 2020 Dec; 29(4)():124-127. PubMed ID: 34018172
[TBL] [Abstract][Full Text] [Related]
14. The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions.
Hardy TA; Guo Y; Flanagan EP; Lucchinetti CF; Tobin WO
Mult Scler; 2022 Oct; 28(11):1710-1718. PubMed ID: 35581949
[TBL] [Abstract][Full Text] [Related]
15. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
[TBL] [Abstract][Full Text] [Related]
16. Relapsing Tumefactive Demyelination: A Case Report.
Omerhodžić I; Džurlić A; Lisica D; Mahmutbegović N; Nikšić M; Bilalović N; Suljić E
Acta Med Acad; 2018 Nov; 47(2):193-198. PubMed ID: 30585071
[TBL] [Abstract][Full Text] [Related]
17. Transtentorial herniation from tumefactive multiple sclerosis mimicking primary brain tumor.
Vakharia K; Kamal H; Atwal GS; Budny JL
Surg Neurol Int; 2018; 9():208. PubMed ID: 30488006
[TBL] [Abstract][Full Text] [Related]
18. A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.
Gnanapavan S; Jaunmuktane Z; Baruteau KP; Gnanasambandam S; Schmierer K
BMC Neurol; 2014 Apr; 14():68. PubMed ID: 24694183
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
Eisele P; Konstandin S; Griebe M; Szabo K; Wolf ME; Alonso A; Ebert A; Serwane J; Rossmanith C; Hennerici MG; Schad LR; Gass A
Mult Scler; 2016 Jul; 22(8):1040-7. PubMed ID: 26453681
[TBL] [Abstract][Full Text] [Related]
20. Imaging intralesional heterogeneity of sodium concentration in multiple sclerosis: Initial evidence from
Grist JT; Riemer F; McLean MA; Matys T; Zaccagna F; Hilborne SF; Mason JP; Patterson I; Slough R; Kaggie J; Deen SS; Graves MJ; Jones JL; Coles AJ; Gallagher FA
J Neurol Sci; 2018 Apr; 387():111-114. PubMed ID: 29571845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
